NCT04047576
- Conditions
- Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +1 more
- Locations
-
- Peking University International Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Retroperitoneal Fibrosis
Explore clinical trials studying Retroperitoneal Fibrosis. Study availability and eligibility vary by location and protocol.
12 public trials
5 recruiting studies
Retroperitoneal Fibrosis trial results
NCT05428826
- Conditions
- Fibrosis, Idiopathic Retroperitoneal Fibrosis, Pathologic Processes, +2 more
- Locations
-
- Médecine Interne Agen, France
- Médecine interne Brest, France
- Médecine interne et maladies infectieuses - GH Sud Haut Lévêque Bordeaux, France
- Médecine interne - Ambroise Paré Boulogne-Billancourt, France
Recruiting
National Registry of Rare Kidney Diseases
NCT06065852
- Conditions
- AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, +207 more
- Locations
-
- Zoe Plummer Bristol, South West, United Kingdom
Recruiting
National Registry of IRPF in China
NCT04314323
- Conditions
- Fibrosis, Idiopathic Retroperitoneal Fibrosis, Pathologic Processes, +2 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Recruiting
A Prospective Cohort Study of IRPF in China
NCT04312854
- Conditions
- Fibrosis, Idiopathic Retroperitoneal Fibrosis, Pathologic Processes, +2 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT03133949
- Conditions
- Fibrosis, Idiopathic Aortitis, Pathologic Processes, +2 more
- Locations
-
- CHU Amiens Picardie Amiens, Picardie, France
NCT05133895
- Conditions
- Chronic Periaortitis, Disease Attributes, Disease Progression, +6 more
- Locations
-
- Yunyun Fei Beijing, China
NCT02705638
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +14 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02703194
- Conditions
- Autoimmune Diseases, Digestive System Diseases, Fibrosis, +15 more
- Locations
-
- Chinese PLA General Hospital Beijing, China
Completed
Rituximab in IgG4-RD: A Phase 1-2 Trial
NCT01584388
- Conditions
- Autoimmune Diseases, Autoimmune Pancreatitis, Chronic Disease, +24 more
- Locations
-
Not specified